Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAWho got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on acquisitions? Find out on this week's "Readout LOUD."
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug | 0 | 7 | 25-06-2026 |
| 2 | STAT+: Embryo editing advances reignite ethical debates | 0 | 5 | 26-06-2026 |
| 3 | Supreme Court rules in weedkiller cancer case | 0 | 5 | 26-06-2026 |
| 4 | What is pulmonary hypertension and why would a new GLP-1 help? | 0 | 5 | 26-06-2026 |
| 5 | Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity | 7 | 8 | 31-07-2025 |
| 6 | Taxation With Representation: Sidley, Paul Weiss, Kirkland | 0 | 5 | 26-06-2026 |
| 7 | STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more | 0 | 3 | 26-06-2026 |
| 8 | Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days | 0 | 5 | 31-07-2025 |
| 9 | Dr. Bal Nandra: Common misconceptions about weight loss medications | 0 | 5 | 26-06-2026 |
| 10 | 3 Firms Steer Cargo Drone Co.'s $800M SPAC Merger | 0 | 5 | 26-06-2026 |